Extended first-trimester screening using multiple sonographic markers and maternal serum biochemistry: A five-year prospective study

Fetal Diagnosis and Therapy

Volumn 35, Issue 4, 2014, Pages 296-301

  Hsiao, Ching Hua ^a,b   Cheng, Po Jen ^c   Shaw, S W Steven ^c   Hsu, Jenn Jeih ^c   Chen, Ran Chou ^a,b   Tseng, Yin Jiun ^b   Chu, Woei Chyn ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

First trimester trisomy screening; Free human chorionic gonadotropin; Nuchal translucency; Pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; CHORIONIC GONADOTROPIN BETA SUBUNIT;

47, XXY; ADULT; ALGORITHM; ANEUPLOIDY; ARTICLE; DUCTUS VENOSUS; FALSE POSITIVE RESULT; FEMALE; FETUS ECHOGRAPHY; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; KARYOTYPE 47,XXX; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM SCREENING TEST; MONOSOMY X; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; TRICUSPID VALVE REGURGITATION; TRISOMY 13; TRISOMY 18; TRISOMY 21; 47,XXY SYNDROME; BLOOD BIOCHEMISTRY; CHINESE; CHROMOSOME ABERRATION; CLASSIFICATION ALGORITHM; MATERNAL SERUM; NASAL BONE; SENSITIVITY ANALYSIS; BLOOD; BLOOD FLOW; COMPUTER PROGRAM; ECHOGRAPHY; KARYOTYPING; METABOLISM; PREGNANCY; SENSITIVITY AND SPECIFICITY; TRISOMY;

ADULT; ALGORITHMS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; KARYOTYPING; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; SOFTWARE; TRISOMY;

EID: 84902543972     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000357564     Document Type: Article

References (24)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K: Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869
2. Nicolaides KH: Nuchal translucency and other first-Trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45-67
3. Mulvey S, Wallace EM: Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. BJOG 2000; 107: 1302-1305
4. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O: Multicenter study of first-Trimester screening for trisomy 21 in 75,821 pregnancies: Results and estimation of the potential impact of individual risk-orientated twostage first-Trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226. (Pubitemid 40432687
5. Office for National Statistics: Annual Birth Reporting Statistics, Department of Health, Taiwan, ROC, 1990-1993
6. Jou HJ, Kou YS, Hsu JJ, Shyu MK, Heieh TT, Hsieh FJ: The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-Trimester maternal serum screening. Prenat Diagn 2005; 25: 665-670
7. Spencer K, Heath V, El-Sheikhah A, Ong CYT, Nicolaides KH: Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: A study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 2005; 25: 365-369. (Pubitemid 40813777
8. Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Spencer K, Lau TK: First-Trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007; 29: 14-17. (Pubitemid 46142693
9. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346. (Pubitemid 28352196
10. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH: First-Trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-Associated plasma protein-A: Impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493-502
11. Wright D, Spencer K, Kagan KK, Torring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH: First-Trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 2010; 36: 404-411
12. Nicolaides KH: The 11 to 13 + 6 Weeks Scan. London, The Fetal Medicine Foundation, 2005; http://www.fetalmidicine.com
13. Kagan KO, Wright D, Valencia CNM, Nicolaides KH: Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free b-hCG and PAPPA. Hum Reprod 2008; 23: 1968-1975
14. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH: A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383
15. Sahota DS, Leung TY, Fung TY, Chan LW, Law LW, Lau TK: Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-Trimester screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 33: 387-393
16. Leung TY, Spencer K, Leung TN, Fung TY, Lau TK: Higher median levels of free betahCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. Fetal Diagn Ther 2006; 21: 140-143
17. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH: Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003; 23: 306-310. (Pubitemid 36457264
18. Leung TY, Sahota D, Chan LW, Law LW, Fung TY, Lau TK: Fetal nasal bone status in Chinese women undergoing first-Trimester screening for trisomy 21. Am J Obstet Gynecol 2008; 199: 521.e1-5
19. Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH: Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33: 259-264
20. Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH: Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33: 512-517
21. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH: Fetal tricuspid regurgitation at the 11+0 to 13+6-week scan: Association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006; 27: 609-612. (Pubitemid 43967360
22. Kagan K, Valencia C, Livanos P, Wright D, Nicolaides KH: Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. Ultrasound Obstet Gynecol 2009; 33: 18-22
23. Ghafari SR, Tahmasebpour AR, Jamal A, Hantoushzadeh S, Eslamian L, Marsooi V, Fattahi F, Rajaei M, Niroomanesh S, Borna S, Beigi A, Khazardoost S, Saleh-Gargari S, Rahimi-Sharbaf F, Farrokhi B, Bayani N, Tehrani SE, Shahsavan K, Farzan S, Moossavi S, Ramezanadeh F, Dastan J, Rafati M: First-Trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: A 5-year prospective study. Ultrasound Obstet Gynecol 2012; 39: 528-534
24. Snijders RJM, Sebire NJ, Nicolaides KH: Maternal age and gestational age specific risks for chromosomal defects. Fetal Diag Ther 1995; 10: 356-357.